Future Innovation Driving Radioligand Therapy Forward Innovation remains central to the ongoing evolution of the Radioligand Therapy (RLT) Market. Researchers worldwide are exploring new ligands capable of targeting a wider range of cancer markers. Ref - https://www.marketresearchfuture.com/reports/radioligand-therapy-rlt-market-11824 Artificial intelligence tools are beginning to assist physicians in analyzing imaging data. Improved tumor detection helps identify patients who may benefit most from therapy. Miniaturized radiation delivery concepts are also under investigation. Scientists aim to maximize tumor destruction while further minimizing exposure to healthy tissues.